NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
5.65
+1.25 (28.41%)
Aug 4, 2026, 1:33 PM EDT - Market open
NextCure Market Cap
NextCure has a market cap or net worth of $20.41 million as of August 4, 2026. Its market cap has increased by 55.95% in one year.
Market Cap
20.41M
Enterprise Value
-5.22M
1-Year Change
55.95%
Ranking
Category
Stock Price
$5.65
ChartMarket Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $20.41M, a decrease of -95.32%. That is a compound annual growth rate of -34.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 20.41M | -58.97% |
| Dec 31, 2025 | 49.74M | 130.37% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jasper Therapeutics | 16.94M |
| NeuroSense Therapeutics | 16.89M |
| Citius Pharmaceuticals | 16.30M |
| OSR Health | 15.81M |
| Vyome Holdings | 15.16M |
| Passage Bio | 15.08M |
| Cyclerion Therapeutics | 14.78M |
| Pasithea Therapeutics | 14.71M |